Literature DB >> 16101487

Camptothecin: roles of the D and E rings in binding to the topoisomerase I-DNA covalent binary complex.

Sidney M Hecht1.   

Abstract

The alkaloid camptothecin is the prototypical DNA topoisomerase I poison. This core structure has formed the basis for two marketed antitumor agents and numerous clinical candidates, and has been the focus of many synthetic and medicinal chemistry studies. Recent reports have furthered our understanding of the roles played by the D and E rings of camptothecin in stabilization of the enzyme-DNA-camptothecin ternary complex. Important parameters for further study and optimization include the facility of E-ring lactone hydrolysis and the prospects for replacing the E ring with more stable structures, the role of the 14-CH group in binary complex binding, and the effect of ternary complex dynamics on the expression of cytotoxicity by the camptothecins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16101487     DOI: 10.2174/1568011054222373

Source DB:  PubMed          Journal:  Curr Med Chem Anticancer Agents        ISSN: 1568-0118


  5 in total

1.  An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas.

Authors:  Ming-Huang Chen; Wen-Chi Chou; Chin-Fu Hsiao; Shih Sheng Jiang; Hui-Jen Tsai; Yi-Chang Liu; Chiun Hsu; Yan-Shen Shan; Yi-Ping Hung; Chia-Hsun Hsich; Chao-Hua Chiu; Ta-Chih Liu; Shih-Feng Cho; Tsang-Wu Liu; Yee Chao
Journal:  Oncologist       Date:  2019-12-18

2.  A theoretical study of some new analogues of the anti-cancer drug camptothecin.

Authors:  Nihar R Jena; Phool C Mishra
Journal:  J Mol Model       Date:  2006-10-06       Impact factor: 1.810

3.  Towards establishment of a plant-based model to assess the novel anti-cancerous lead molecule(s): An in silico, in vivo and in vitro assessment of some potential anti-cancerous drugs on Lathyrus sativus L.

Authors:  Aveek Samanta; Saptadipa Banerjee; Tilak Raj Maity; Jangala Jahnavi; Siraj Datta
Journal:  Protoplasma       Date:  2022-02-23       Impact factor: 3.186

4.  Single-molecule observations of topotecan-mediated TopIB activity at a unique DNA sequence.

Authors:  Daniel A Koster; Fabian Czerwinski; Ludovic Halby; Aurélien Crut; Pierre Vekhoff; Komaraiah Palle; Paola B Arimondo; Nynke H Dekker
Journal:  Nucleic Acids Res       Date:  2008-02-21       Impact factor: 16.971

5.  TLC388 Induces DNA Damage and G2 Phase Cell Cycle Arrest in Human Non-Small Cell Lung Cancer Cells.

Authors:  Kun-Ming Wu; Chih-Wen Chi; Jerry Cheng-Yen Lai; Yu-Jen Chen; Yu Ru Kou
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.